Evidence map›Paper›PMID 33619425›Full record

ArticleBulletin of the National Research Centre2021

Efficacy of neurofeedback as a treatment modality for children in the autistic spectrum.

L Mekkawy

Open access · diamondAbstract read
In one paragraph

Article in Bulletin of the National Research Centre, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

L MekkawyLecturer of Pediatric Neurodisabilities, Department of Medical Studies, Faculty of Postgraduate Childhood Studies, Ain Shams University, Cairo, 2020 Egypt.
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeurofeedback (NFB) has been conceded as a convenient measure for both identifying and remodeling neural pliability of brain cells; it is a mean through which participants can have voluntary control on their brain waves being expressed on the EEG. Forty-two autistic children received a NFB therapy aiming at improving their cognitive abilities.

resultsNFB succeeded to decrease children's high theta/beta ratio by inhibiting theta activity and intensifying beta activity over different sessions. Following therapy, the children's cognitive functions were found to show comparative improvement compared to pre-treatment assessment on a range of different tasks. Auxiliary improvements were found in their social, thought and attention domains.

conclusionThese findings propose a basic cognitive function impairment in autism spectrum disorder that can be reduced through specific NFB treatment.

Indexed as

Autism spectrum disorderNeurofeedbackTheta/beta ratio

Identifiers

PMID33619425
PMCPMC7889708
OpenAlexW3132216487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.